Ignite Creation Date:
2025-12-24 @ 9:58 PM
Ignite Modification Date:
2026-02-06 @ 7:25 AM
Study NCT ID:
NCT02590432
Status:
COMPLETED
Last Update Posted:
2019-08-22
First Post:
2015-10-27
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
An Open-Label, Long-term Study to Assess the Immunogenicity of LINZESS® (Linaclotide) Administered Orally to Adult Participants With Irritable Bowel Syndrome With Constipation or Chronic Idiopathic Constipation
Sponsor:
Forest Laboratories
Organization:
Conditions & Keywords Data
Conditions: